Journal of Ultrasound in Medicine, Vol 20, Issue 10 1053-1063, Copyright © 2001 by American Institute of Ultrasound in Medicine

JOURNAL ARTICLE

Isolated sonographic markers for detection of fetal Down syndrome in the second trimester of pregnancy

D. A. Nyberg, V. L. Souter, A. El-Bastawissi, S. Young, F. Luthhardt and D. A. Luthy
Seattle Ultrasound Associates, Washington 98115, USA.

OBJECTIVE: To determine whether sonographic "markers" are associated with fetal Down syndrome during the second trimester and to estimate the degree of risk of individual markers using likelihood ratios. METHODS: Second-trimester (14-20 weeks) sonographic findings in 186 fetuses with trisomy 21 were compared with a control group of 8728 consecutive control fetuses. Six markers were evaluated: nuchal thickening, hyperechoic bowel, shortened femur, shortened humerus, echogenic intracardiac focus, and renal pyelectasis. RESULTS: Major or structural abnormalities were observed in 31 fetuses with trisomy 21 (16.7%) and 53 control fetuses (0.6%) (P< .001). Some type of sonographic finding (major abnormality, minor marker, or both) was observed in 68.8% of fetuses with trisomy 21 compared with 13.6% of control fetuses (P < .001). An isolated minor or "soft" marker was the only sonographic finding in 42 (22.6%) of 186 fetuses with trisomy 21 compared with 987 (11.3%) of 8728 control fetuses (P < .001). Nuchal thickening (P < .001; likelihood ratio, 11) and hyperechoic bowel (P < .001; likelihood ratio, 6.7) showed the strongest association with trisomy 21 as isolated markers, followed by shortened humerus (likelihood ratio, 5.1), echogenic intracardiac focus (likelihood ratio, 1.8), shortened femur (likelihood ratio, 1.5), and pyelectasis (likelihood ratio, 1.5). Echogenic intracardiac focus was the single most common isolated marker in both affected fetuses (7.1%) and control fetuses (3.9%) but carried a low risk (P= .046; likelihood ratio, 1.8). CONCLUSIONS: A single soft marker is commonly encountered during the second trimester among fetuses with trisomy 21. The risk of fetal Down syndrome, reflected by likelihood ratios, was determined for 6 individual markers. This information can be combined with the a priori risk to estimate the individual patient risk for fetal Down syndrome.

This article has been cited by other articles:

				C. Papp, A. Beke, G. Mezei, Z. Szigeti, Z. Ban, and Z. Papp Prenatal Diagnosis of Turner Syndrome: Report on 69 Cases J. Ultrasound Med., June 1, 2006; 25(6): 711 - 717. [Abstract] [Full Text] [PDF]

				P. M. Doubilet, J. A. Copel, C. B. Benson, R. O. Bahado-Singh, and L. D. Platt Choroid Plexus Cyst and Echogenic Intracardiac Focus in Women at Low Risk for Chromosomal Anomalies: The Obligation to Inform the Mother J. Ultrasound Med., July 1, 2004; 23(7): 883 - 885. [Full Text] [PDF]

				C. Coco, P. Jeanty, and C. Jeanty An Isolated Echogenic Heart Focus Is Not an Indication for Amniocentesis in 12,672 Unselected Patients J. Ultrasound Med., April 1, 2004; 23(4): 489 - 496. [Abstract] [Full Text] [PDF]

				A. Vintzileos, C. Walters, and L. Yeo Absent Nasal Bone in the Prenatal Detection of Fetuses With Trisomy 21 in a High-Risk Population Obstet. Gynecol., May 1, 2003; 101(5): 905 - 908. [Abstract] [Full Text] [PDF]

				A. Sotiriadis, G. Makrydimas, and J. P. A. Ioannidis Diagnostic Performance of Intracardiac Echogenic Foci for Down Syndrome: A Meta-analysis Obstet. Gynecol., May 1, 2003; 101(5): 1009 - 1016. [Abstract] [Full Text] [PDF]

				B. Bromley, E. Lieberman, T. D. Shipp, and B. R. Benacerraf The Genetic Sonogram: A Method of Risk Assessment for Down Syndrome in the Second Trimester J. Ultrasound Med., October 1, 2002; 21(10): 1087 - 1096. [Abstract] [Full Text] [PDF]